CPS Specialty Pharmacy Research Named Top 5% at ISPOR 2026

All Posts

CPS Specialty Pharmacy Research Named Top 5% at ISPOR 2026

Published: May 2026

Congratulations to our CPS authors!

 

It’s an honor to share that CPS’ specialty pharmacy research has been featured this week at ISPOR 2026 and recognized as a Top 5% Finalist for the ISPOR 2026 Research Presentation Awards.

 

The study, "Identifying Determinants of Medication Persistence in Rheumatoid Arthritis Using Machine Learning and Regression Analysis," outlines how health-system specialty pharmacies (HSSPs) can influence medication persistence among patients with rheumatoid arthritis by supporting medication access, clinical management, and monitoring.

 

Learn more about the esteemed research presented at ISPOR here.

Related Posts

 

Submit your contact information below to receive insights from our team of pharmacy solutions experts.